Drug Recall List - Blue Cross Blue Shield of Michigan

Drug Recall List Drug

Recall Details

Last Updated: March 2022

Contact

Date

Drug Recall Class*

Alprazolam 06042950418

CGMP Deviation

hydrALAZINE 00904644061

Failed Impurities/Degradation Specifications

Alprazolam C-IV 06191983660 72189005860

PALIPERIDONE EXTENDEDRELEASE 00904693761

Oxycodone Hydrochloride 00360687406 06068-40677 06068740640

CGMP Deviations

Failed Dissolution Specifications

Impurity failure at 0-time of the repackaged lot

If you have questions about this recall, Golden State Medical Supply Inc., 1-805-477-9866 Ext 4.

March 2022

If you have questions about this recall, The Harvard Drug Group, 1800-875-0123

March 2022

If you have questions about this recall, Direct Rx, 1-678-619-5510

March 2022

If you have questions about this recall, The Harvard Drug Group, 1800-875-0123. If you have questions about this recall, American Health Packaging, 1-614492-8177.

March 2022

March 2022

Class II Class II Class II Class II Class II

* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.

Methylphenidate Hydrochloride 6498022101

Failed Tablet Specifications

Diazepam 00527176836

Failed Impurities/Degradation Specifications

If you have questions about this recall, RISING PHARMACEUTICALS, 1-866-562-4597 If you have questions about this recall, Lannett Company, Inc.1-215-3339000

March 2022

February 2022

Class II Class II

Morphine Sulfate 73177010504

Labeling; label mix-up

If you have questions about this recall, STAQ Pharma, Inc., 1833-397-0106.

February 2022

Class I

Hydromorphone HCL 73177010405

Labeling; label mix-up

If you have questions about this recall, STAQ Pharma, Inc., 1833-397-0106.

February 2022

Class I

Doxylamine Succinate and Pyridoxine Hydrochloride 0591-2132-01

Failed Dissolution Specifications

If you have questions about this recall, Teva Pharmaceuticals USA, 1-800-545-8800

February 2022

Class II

Tretinoin

Failed Dissolution Specifications

If you have questions

February Class II

00555080802

about this recall,

2022

Teva Pharmaceuticals

USA, 1-800-545-8800

* Drug Recall Class

Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death.

Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious

adverse health consequences is remote.

Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.

Proctofoam 00037682210

Metformin Hydrochloride 07257803601

Proctofoam HC 00037682210

Diazepam 00527176836

Trypan Blue 05446134801

cGMP deficiencies CGMP Deviations

cGMP deficiencies Failed Impurities/Degradation Specifications CGMP Deviations

If you have questions about this recall, call Mylan 1-888-406-9305

February 2022

If you have questions about this recall, VIONA PHARMACEUTICALS INC, 1-888-304-5022

February 2022

If you have questions about this recall, call Mylan 1-888-406-9305

February 2022

If you have questions about this recall, Lannett Company, Inc.1-215-3339000.

February 2022

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II Class II

Class II Class II Class II

* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.

Vancomycin HCl 05446134801

CGMP Deviations

Tetracaine HCl 05446119503

CGMP Deviations

Promethazine HCl Topical 05446134101

CGMP Deviations

Vitamin K Oral 05446113203

CGMP Deviations

Lidocaine HCl/Phenylephrine HCl CGMP Deviations 05446104503

Phenol, Topical 05446121103

CGMP Deviations

Profound-PE Dental Gel 05446040810

CGMP Deviations

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II

February 2022

Class II

February 2022

Class II

February 2022

Class II

February 2022

Class II

February 2022

Class II

February 2022

Class II

* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.

Profound-PE Dental Gel11 05446101810

CGMP Deviations

Profound Dental Gel 05446079010 05446040710

Lidocaine HCl / Oxymetazoline HCl 05446125601

CGMP Deviations CGMP Deviations

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II

February 2022

Class II

February 2022

Class II

LET Topical Gel 05446060701

LT Topical 05446164701

Dibutyl Squaric Acid 05446104703 05446115603

Dexamethasone sodium phosphate 05446062201

CGMP Deviations CGMP Deviations CGMP Deviations CGMP Deviations

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall,

February 2022

Class II

February 2022

Class II

February 2022

Class II

February 2022

Class II

* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.

Cantharidin PLUS 05446097003

CGMP Deviations

Cantharidin Gel 05446057203

CGMP Deviations

Vancomycin HCl 05446073601

Lack of Assurance of Sterility

Betadine (povidone-iodine) 05446168001

Lack of Assurance of Sterility

Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/ Ketorolac 05446085903

Lack of Assurance of Sterility

Edge Pharma, LLC. 1802-992-1178.

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II

February 2022

Class II

February 2022

Class II

February 2022

Class II

February 2022

Class II

* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.

Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/Ketorolac 05446099301

Lack of Assurance of Sterility

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II

Phenylephrine HCl/Tropicamide Lack of Assurance of Sterility 05446081501

Phenylephrine HCl/Lidocaine 05446111801

Lack of Assurance of Sterility

Phenylephrine HCl 05446127001 05446154505 05446154410 05446165201

Lack of Assurance of Sterility

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II

February 2022

Class II

February 2022

Class II

MVASI 05446166113

Neostigmine 05446154905

Lack of Assurance of Sterility Lack of Assurance of Sterility

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II

February 2022

Class II

* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.

Moxifloxacin 05446105001

Mitomycin-C 05446141601 05446100901 05446101101

Methotrexate 05446150505

Methacholine 05446160005 05446124601 05446124701 05446124901

Lidocaine HCL / Bupivacaine HCL 05446154818

Gemcitabine 05446156650

Lack of Assurance of Sterility Lack of Assurance of Sterility Lack of Assurance of Sterility Lack of Assurance of Sterility

Lack of Assurance of Sterility Lack of Assurance of Sterility

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II

February 2022

Class II

February 2022

Class II

February 2022

Class II

If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178. If you have questions about this recall, Edge Pharma, LLC. 1802-992-1178.

February 2022

Class II

February 2022

Class II

* Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Class 2 Recall: Using the drug may cause temporary or medical reversible adverse health consequences, the probability of serious adverse health consequences is remote. Class 3 Recall: Using the drug is not likely to cause adverse health consequences.

NOTE: This is not a complete list of all recalls. Please see >Drugs>Drug Safety and Availability> Drug Recalls for additional information.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download